Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEVPAC: Bevacizumab + Paclitaxel in HER2- MBC
NCT01722968Phase 2Completed
- Start
- Nov 2012
- Primary completion
- Jun 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer. Started Nov 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01722968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01722968.